Обзор акций Novacyt (NVYTF)

Novacyt SAS engages in the development and sale of cancer and infectious disease diagnostic products. It operates through the Corporate and Diagnostics; and Molecular Products segments. The Corporate and Diagnostics segment includes diagnostic activities in laboratories, and the manufacturing and distribution of reagents and kits for bacterial and blood tests. The Molecular Products segment comprises of design, manufacture, and distribution of test kits for certain diseases in humans, animals and food products. The company was founded by Eric Peltier, Gerald Ulrich, and Jean-Pierre Crinelli on July 3, 2006 and is headquartered in Velizy-Villacoublay, France.